MARKET

CLLS

CLLS

Cellectis
NASDAQ
2.140
-0.110
-4.89%
Pre Market: 2.010 -0.13 -6.07% 08:37 06/18 EDT
OPEN
2.160
PREV CLOSE
2.250
HIGH
2.160
LOW
2.110
VOLUME
6.63K
TURNOVER
0
52 WEEK HIGH
3.774
52 WEEK LOW
0.9628
MARKET CAP
213.90M
P/E (TTM)
0.0000
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CLLS last week (0610-0614)?
Weekly Report · 1d ago
Cellectis Pioneers Non-Viral Gene Therapy for SCD
TipRanks · 5d ago
CELLECTIS UNVEILS A NON-VIRAL GENE THERAPY APPROACH FOR SICKLE CELL DISEASE IN NATURE COMMUNICATIONS
Reuters · 5d ago
Cellectis Is Maintained at Outperform by Oppenheimer
Dow Jones · 5d ago
Cellectis Price Target Cut to $10.00/Share From $11.00 by Oppenheimer
Dow Jones · 5d ago
Oppenheimer Maintains Outperform on Cellectis, Lowers Price Target to $10
Benzinga · 5d ago
Analysts Conflicted on These Healthcare Names: SAGE Therapeutics (SAGE), Bristol-Myers Squibb (BMY) and Cellectis SA (CLLS)
TipRanks · 6d ago
Weekly Report: what happened at CLLS last week (0603-0607)?
Weekly Report · 06/10 09:38
More
About CLLS
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Webull offers Cellectis SA (ADR) stock information, including NASDAQ: CLLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLLS stock methods without spending real money on the virtual paper trading platform.